{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:17:45Z","timestamp":1789910265910,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jhep.2017.10.014","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T11:01:50Z","timestamp":1508929310000},"page":"412-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["A novel orally available small molecule that inhibits hepatitis B virus expression"],"prefix":"10.1016","volume":"68","author":[{"given":"Henrik","family":"Mueller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Wildum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souphalone","family":"Luangsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Walther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Tropberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Ottaviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhe","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil John","family":"Parrott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitao David","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Schmucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Racek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Hoflack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Kueng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriane","family":"Point","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"L\u00fctgehetmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna","family":"Rapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tassilo","family":"Volz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Dandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.T.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Javanbakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2017.10.014_b0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.patbio.2009.11.001","article-title":"Pathogenesis of hepatitis B virus infection","volume":"58","author":"Chisari","year":"2010","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.jhep.2017.10.014_b0010","unstructured":"WHO 2016;Fact sheet no. 204."},{"key":"10.1016\/j.jhep.2017.10.014_b0015","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021501","article-title":"Antiviral therapies and prospects for a cure of chronic hepatitis B","volume":"5","author":"Zoulim","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jhep.2017.10.014_b0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/liv.12749","article-title":"HBV and the immune response","volume":"35","author":"Ferrari","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2017.10.014_b0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrgastro.2011.33","article-title":"Hepatitis B therapy","volume":"8","author":"Kwon","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2017.10.014_b0030","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/eji.200940102","article-title":"How chronic viral infections impact on antigen-specific T-cell responses","volume":"40","author":"Frebel","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2017.10.014_b0035","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.4049\/jimmunol.1502061","article-title":"Clearing persistent extracellular antigen of hepatitis b virus: an immunomodulatory strategy to reverse tolerance for an effective therapeutic vaccination","volume":"196","author":"Zhu","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2017.10.014_b0040","doi-asserted-by":"crossref","first-page":"e1003490","DOI":"10.1371\/journal.ppat.1003490","article-title":"CD40 activation rescues antiviral CD8(+) T cells from PD-1-mediated exhaustion","volume":"9","author":"Isogawa","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2017.10.014_b0045","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/cmi.2015.80","article-title":"Effective intrahepatic CD8+ T-cell immune responses are induced by low but not high numbers of antigen-expressing hepatocytes","volume":"13","author":"Ochel","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhep.2017.10.014_b0050","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/935295","article-title":"Hepatitis B surface antigen could contribute to the immunopathogenesis of hepatitis B virus infection","volume":"2013","author":"Kondo","year":"2013","journal-title":"ISRN Gastroenterol"},{"key":"10.1016\/j.jhep.2017.10.014_b0055","doi-asserted-by":"crossref","first-page":"e15324","DOI":"10.1371\/journal.pone.0015324","article-title":"Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function","volume":"6","author":"Woltman","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2017.10.014_b0060","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2567.2008.02896.x","article-title":"Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus","volume":"126","author":"Op den Brouw","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jhep.2017.10.014_b0065","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.intimp.2005.06.004","article-title":"Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers","volume":"5","author":"Chen","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jhep.2017.10.014_b0070","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jhep.2016.12.024","article-title":"Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B","volume":"66","author":"Lebosse","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.014_b0075","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jhep.2015.02.037","article-title":"The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection","volume":"63","author":"Gane","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.014_b0080","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2893.2010.01315.x","article-title":"Control of hepatitis B virus at the level of transcription","volume":"17","author":"Quasdorff","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2017.10.014_b0085","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2017.10.014_b0090","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI58847","article-title":"IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome","volume":"122","author":"Belloni","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2017.10.014_b0095","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jhep.2012.12.008","article-title":"The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus","volume":"58","author":"Volz","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.014_b0100","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jhep.2013.10.021","article-title":"Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration","volume":"60","author":"Allweiss","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.014_b0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/135965350801300106","article-title":"Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication","volume":"13","author":"Lutgehetmann","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2017.10.014_b0110","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.1073\/pnas.0504273102","article-title":"Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids","volume":"102","author":"Wieland","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2017.10.014_b0115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000329809","article-title":"Immune control of hepatitis B virus","volume":"29","author":"Bauer","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhep.2017.10.014_b0120","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021428","article-title":"Immune response in hepatitis B virus infection","volume":"5","author":"Tan","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jhep.2017.10.014_b0125","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nri.2016.69","article-title":"Immune responses and immunopathology in acute and chronic viral hepatitis","volume":"16","author":"Shin","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2017.10.014_b0130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins","year":"2011","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jhep.2017.10.014_b0135","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.coviro.2011.10.026","article-title":"Type I interferons: diversity of sources, production pathways and effects on immune responses","volume":"1","author":"Swiecki","year":"2011","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jhep.2017.10.014_b0140","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jhep.2015.11.032","article-title":"In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides","volume":"64","author":"Billioud","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.014_b0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-1-4939-1538-5_10","article-title":"Targeted in vivo delivery of siRNA and an endosome-releasing agent to hepatocytes","volume":"1218","author":"Sebestyen","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.jhep.2017.10.014_b0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1060028016668897","article-title":"Sofosbuvir\/velpatasvir: the first pangenotypic direct-acting antiviral combination for hepatitis C","volume":"51","author":"Chahine","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jhep.2017.10.014_b0155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40265-015-0361-6","article-title":"Abacavir\/dolutegravir\/lamivudine single-tablet regimen: a review of its use in HIV-1 infection","volume":"75","author":"Greig","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.jhep.2017.10.014_b0160","doi-asserted-by":"crossref","first-page":"e0169648","DOI":"10.1371\/journal.pone.0169648","article-title":"The Smc5\/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection","volume":"12","author":"Niu","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jhep.2017.10.014_b0165","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.29348","article-title":"Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages","volume":"66","author":"Cheng","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.014_b0170","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.jhep.2016.02.016","article-title":"New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus","volume":"64","author":"Durantel","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.014_b0175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000360948","article-title":"Inhibitors of hepatitis B virus attachment and entry","volume":"57","author":"Lempp","year":"2014","journal-title":"Intervirology"},{"key":"10.1016\/j.jhep.2017.10.014_b0180","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jhep.2016.02.012","article-title":"Experimental in vitro and in vivo models for the study of human hepatitis B virus infection","volume":"64","author":"Allweiss","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.014_b0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12864-017-3661-2","article-title":"Detect tissue heterogeneity in gene expression data with BioQC","volume":"18","author":"Zhang","year":"2017","journal-title":"BMC Genomics"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817323930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817323930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T06:38:23Z","timestamp":1659681503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827817323930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0168827817323930"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2017.10.014","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel orally available small molecule that inhibits hepatitis B virus expression","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2017.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}